| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 04/25/2007 | CN1311870C Interleukin 6 production inhibitor |
| 04/25/2007 | CN1311869C Biological collagen injection as substituted blood plasma and its preparation method |
| 04/25/2007 | CN1311866C Use of erythopoietin |
| 04/24/2007 | US7208524 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 04/24/2007 | US7208479 Peritoneal dialysis solution containing modified icodextrins |
| 04/24/2007 | US7208266 Comprises oxidized polyoxyethylene glycol modified by derivatives of esterified gallic acid, produced by keto-enol equilibrium reaction |
| 04/24/2007 | US7208147 Modified granulocyte macrophage colony stimulating factor (GM-CSF) with reduced immunogenicity |
| 04/24/2007 | CA2279648C Haemostatic aerosol composition |
| 04/24/2007 | CA2166811C Tricyclic inhibitors of the gpiibiiia receptor |
| 04/19/2007 | WO2007044574A2 Pharmaceutical compositions, methods of preparation thereof, and methods of treatment |
| 04/19/2007 | WO2007044560A2 Modulators of atp-binding cassette transporters |
| 04/19/2007 | WO2007043568A1 S1p3 receptor antagonist |
| 04/19/2007 | WO2007043287A1 TRANSCRIPTIONAL REGULATION OF HIGH AFFINITY IgE RECEPTOR Ϝ-CHAIN |
| 04/19/2007 | WO2007042470A2 Antithrombotic compound |
| 04/19/2007 | WO2007042469A2 Anticoagulant antithrombotic dual inhibitors comprising a biotin label |
| 04/19/2007 | WO2007042146A1 Microangiopathy treatment and prevention |
| 04/19/2007 | WO2007042010A2 Synergistic pharmaceutical composition containing a peptide with 2 to 5 amino acids |
| 04/19/2007 | WO2007009707A3 Use of substituted pyrazoline compounds for the treatment of coagulation related diseases |
| 04/19/2007 | WO2006114448A3 A closed container comprising an activated factor vii polypeptide, processes for the preparation of the same, and a kit and a method for use of the kit |
| 04/19/2007 | WO2006091775A3 Tropoelastin for promoting endothelial cell adhesion or migration |
| 04/19/2007 | WO2006088972A3 Use of modulatirs of compounds of tgf-beta superfamily to regulate hepcidin-mediated iron metabolism |
| 04/19/2007 | WO2006084210A3 Hif modulating compounds and methods of use thereof |
| 04/19/2007 | WO2006033005A8 Thrombopoietin receptor agonists |
| 04/19/2007 | WO2005097783A8 Thiocarbamoylprolines |
| 04/19/2007 | US20070088085 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 04/19/2007 | US20070088033 Diaryl Substituted Pyridinones |
| 04/19/2007 | US20070088008 treating psoriasis with e.g. 19-nor-2beta-ethyl-1alpha,25-dihydroxyvitamin D3 |
| 04/19/2007 | US20070087958 Compounds and compositions for delivering active agents |
| 04/19/2007 | US20070087388 G protein coupled receptor |
| 04/19/2007 | DE102005049385A1 Imidazolderivate als Inhibitoren von TAFIa Imidazole derivatives as inhibitors of TAFIa |
| 04/19/2007 | CA2626011A1 S1p3 receptor antagonist |
| 04/19/2007 | CA2625661A1 Synergistic pharmaceutical composition containing a peptide with 2 to 5 amino acids |
| 04/19/2007 | CA2624963A1 Microangiopathy treatment and prevention |
| 04/19/2007 | CA2624683A1 Modulators of atp-binding cassette transporters |
| 04/19/2007 | CA2624588A1 Anticoagulant antithrombotic dual inhibitors comprising a biotin label |
| 04/18/2007 | EP1775297A2 Adenosine receptor antagonists and methods of making and using the same |
| 04/18/2007 | EP1775293A1 Antiplatelet agent and process for producing the same |
| 04/18/2007 | EP1773867A2 Proteinaceous compounds and uses therefor |
| 04/18/2007 | EP1773855A1 Novel compounds that inhibit factor xa activity |
| 04/18/2007 | EP1773786A2 Five-membered heterocycles useful as serine protease inhibitors |
| 04/18/2007 | EP1773778A1 Method for the preparation of crystal forms of torsemide in a pure state |
| 04/18/2007 | EP1773771A2 Compounds and methods for treatment of thrombosis |
| 04/18/2007 | EP1773370A1 Combination therapies employing platelet aggregation drugs |
| 04/18/2007 | EP1773335A2 Nanoparticle dispersion containing lactam compound |
| 04/18/2007 | EP1545534B1 Use of 4-pyridylmethyl-phthalazine derivatives for the manufacture of a medicament for the treatment of myelodysplastic syndromes |
| 04/18/2007 | EP1401479B1 Detection and therapy of vulnerable plaque with photodynamic compounds |
| 04/18/2007 | EP1379266B1 Modified annexin proteins and prevention and treatment of thrombosis |
| 04/18/2007 | EP1352063B1 Receptor nucleic acids and polypeptides |
| 04/18/2007 | EP1345918B1 1,5 benzothiazepines and their use as antihyperlipidemics |
| 04/18/2007 | EP1192261B1 22025, a novel human cyclic nucleotide phosphodiesterase |
| 04/18/2007 | EP1137408B1 Agent for lowering endothelin levels |
| 04/18/2007 | CN1950389A Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 04/18/2007 | CN1950357A Imidazole derivatives used as TAFIA inhibitors |
| 04/18/2007 | CN1950353A Materials and methods for treating coagulation disorders |
| 04/18/2007 | CN1948472A High efficiency expression method of earthworm kinase single component F-II in yeast and product |
| 04/18/2007 | CN1947736A Prepn. method and application of injection contg. Erigeron breviscapus |
| 04/18/2007 | CN1947713A Nano-safflower flavone injection prepn. and its prepn. method |
| 04/18/2007 | CN1947712A Nano-safflower uranidin injection prepn. and its prepn. method |
| 04/18/2007 | CN1947704A Medicinal water-soluble compositions contg. 20(R)-ginsenoside (Rg3), and its prepn. method |
| 04/18/2007 | CN1311081C Stem cell differentiation |
| 04/18/2007 | CN1310949C Bifunctional chimeric profein possessing inhibiting leucocyte function and thrombin activity |
| 04/18/2007 | CN1310921C Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/18/2007 | CN1310915C Pyrido(2,1-a)isoquinoline derivatives as DPP-IV inhibitors |
| 04/18/2007 | CN1310884C Method for producing enantiomer-free N-methyl-N-[(1S)-1-phenyl-2-[(3S)-3-hydroxypyrrolidine-1-y1)ethyl]-2, 2-diphenyl acetamide |
| 04/18/2007 | CN1310672C Osteogenis oligopeptide as blood-formation stimulation articles |
| 04/18/2007 | CN1310642C Methods and compositions to enhance white blood cell count |
| 04/17/2007 | US7205386 Truncated CD200 |
| 04/17/2007 | US7205327 Benzoimidazole or imidazole-2-carbonyl)-amino)-3-methyl butyrylamino)-5-fluoro-4-oxo- derivatives |
| 04/17/2007 | US7205306 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 04/17/2007 | US7205302 Anticoagulants; antilipemic agents; cardiovascular disorders |
| 04/17/2007 | US7205278 Introducing one or more cysteine residues into a polypeptide which permit the stabilization of the polypeptide by formation of at least one bond, preferably a disulfide bond, between different domains of the polypeptide. |
| 04/17/2007 | US7205151 Antiinflammatory agents; skin disorders |
| 04/17/2007 | US7205139 Expression vector comprising nucleotide sequences coding serine protease for use in diagnosis and treatment of thrombotic disorders |
| 04/17/2007 | US7204979 Generation of hematopoietic cells from multipotent neural stem cells |
| 04/17/2007 | CA2386799C Fused cycloheptane and fused azacycloheptane compounds and their as integrin receptor antagonists |
| 04/17/2007 | CA2374635C Sulfuric acid mono-[3-({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-hydroxy-methyl)-2-methoxy-phenyl]ester |
| 04/17/2007 | CA2133205C Stable polypeptide composition |
| 04/17/2007 | CA2100690C Megakaryocyte differentiation factor |
| 04/12/2007 | WO2007040231A1 Quinazoline derivative and pharmaceutical |
| 04/12/2007 | WO2007040123A1 Method for detection of human precursor t cell and precursor b cell |
| 04/12/2007 | WO2007040082A1 Pharmaceutical composition for treatment or prevention of nephritis and method for producing same |
| 04/12/2007 | WO2007039132A1 Novel polymorphous form and the amorphous form of 5-chloro-n-({ (5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide |
| 04/12/2007 | WO2007038869A1 Aptamers comprising arabinose modified nucleotides |
| 04/12/2007 | WO2007014772A3 Direct and indirect effector cell protease receptor-1 (epr-1) inhibitors as antiplatelet agents |
| 04/12/2007 | WO2006119912A3 Use of histones for therapeutic purposes |
| 04/12/2007 | WO2006114401A3 Novel cyclic amines |
| 04/12/2007 | US20070082957 2-chloro-5-(3-oxopropyl)-N-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-benzamide; P2X7 receptor antagonists; inflammatory, immune or cardiovascular diseases |
| 04/12/2007 | US20070082951 protamine-mimetic compounds; calixarenes substituted with amino acids bearing salifiable amino groups; In post-surgical protocols to prevent thromboembolism, clotting and thrombi; to prevent clotting in dialysis circuits; side effects reduction; minimize the risk of hemorrhage in dialysed patients |
| 04/12/2007 | US20070082897 Acylated indanyl amines and their use as pharmaceuticals |
| 04/12/2007 | US20070082341 Human phospholipases |
| 04/12/2007 | US20070081999 Antithrombotic von willebrand factor (vwf) collagen bridging blockers |
| 04/12/2007 | CA2625340A1 Pharmaceutical composition for treatment or prevention of nephritis and method for producing same |
| 04/12/2007 | CA2624310A1 Polymorphic form of 5-chloro-n-({5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide |
| 04/12/2007 | CA2624141A1 Quinazoline derivative and pharmaceutical |
| 04/12/2007 | CA2623818A1 Aptamers comprising arabinose modified nucleotides |
| 04/11/2007 | EP1772516A1 Pharmaceutical compositions for the treatment of thrombosis |
| 04/11/2007 | EP1772456A1 Novel crystalline polymorphs of clopidogrel |
| 04/11/2007 | EP1771441A1 Novel carboxamides for use as xa inhibitors |
| 04/11/2007 | EP1435985B1 Medicament containing activated antithrombin iii |
| 04/11/2007 | EP1392641B1 Substituted cyclohexane-1,4-diamine derivatives |